Hiroshi Ida

Kindai University — Japan

Medicine · Health Sciences

32h-index3.4kcitations172works2.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatocellular Carcinoma Treatment and Prognosis(35), Liver Disease Diagnosis and Treatment(34), Hepatitis C virus research(14), Liver Disease and Transplantation(14), Hepatitis B Virus Studies(12)

Publications143 total

No Correlation Between Proteinuria and Renal Function in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab: ARISE Study
Cancers·2025Open Access
Complete Remission of Acute-onset Autoimmune Hepatitis Following Transcatheter Splenic Arterial Embolization and Splenectomy for Spontaneous Splenic Rupture
Internal Medicine·2025Open Access
Molecular classification of hepatocellular carcinoma based on zoned metabolic feature and oncogenic signaling pathway
Clinical and Molecular Hepatology·2025· 7 citedOpen Access
Proposal of discontinuation criteria of atezolizumab plus bevacizumab after curative conversion therapy for unresectable early-to-intermediate-stage hepatocellular carcinoma: a multicenter proof-of-concept study
Journal of Gastroenterology·2025· 6 citedOpen Access
Peliosis Hepatis Complicated by Scleroderma and Rapidly Progressing to Liver Failure
Internal Medicine·2024· 1 citedOpen Access
Unresectable hepatocellular carcinoma after Fontan surgery: A case report
Kanzo·2023Open Access
171P Retrospective study of the correlation between proteinuria and renal function in patients (pts) with unresectable hepatocellular carcinoma (uHCC) treated with atezolizumab plus bevacizumab (Atezo+Bev): ARISE study
Annals of Oncology·2023Open Access
Two Distinct Characteristics of Immune Microenvironment in Human Hepatocellular Carcinoma with Wnt/β-Catenin Mutations
Liver Cancer·2023· 16 citedOpen Access
A phase 1b study of E7386, a CREB-binding protein (CBP)/β-catenin interaction inhibitor, in combination with lenvatinib in patients with advanced hepatocellular carcinoma.
Journal of Clinical Oncology·2023· 4 cited
Incidence of Hyper Progressive Disease in Combination Immunotherapy and Anti-Programmed Cell Death Protein 1/Programmed Death-Ligand 1 Monotherapy for Unresectable Hepatocellular Carcinoma
Liver Cancer·2023· 13 citedOpen Access
Non-Inflamed Tumor Microenvironment and Methylation/Downregulation of Antigen-Presenting Machineries in Cholangiocarcinoma
Cancers·2023· 13 citedOpen Access
Role of β-Catenin Activation in the Tumor Immune Microenvironment and Immunotherapy of Hepatocellular Carcinoma
Cancers·2023· 26 citedOpen Access
Supplementary Figure 1 from Serum miR-21, miR-29a, and miR-125b Are Promising Biomarkers for the Early Detection of Colorectal Neoplasia
2023Open Access
Supplementary Figure 2 from Serum miR-21, miR-29a, and miR-125b Are Promising Biomarkers for the Early Detection of Colorectal Neoplasia
2023Open Access
Figure Legends for Supplementary Figures from Serum miR-21, miR-29a, and miR-125b Are Promising Biomarkers for the Early Detection of Colorectal Neoplasia
2023Open Access
Data from Serum miR-21, miR-29a, and miR-125b Are Promising Biomarkers for the Early Detection of Colorectal Neoplasia
2023Open Access
Figure Legends for Supplementary Figures from Serum miR-21, miR-29a, and miR-125b Are Promising Biomarkers for the Early Detection of Colorectal Neoplasia
2023Open Access
Supplementary Figure 2 from Serum miR-21, miR-29a, and miR-125b Are Promising Biomarkers for the Early Detection of Colorectal Neoplasia
2023Open Access
Data from Serum miR-21, miR-29a, and miR-125b Are Promising Biomarkers for the Early Detection of Colorectal Neoplasia
2023Open Access
Supplementary Figure 1 from Serum miR-21, miR-29a, and miR-125b Are Promising Biomarkers for the Early Detection of Colorectal Neoplasia
2023Open Access
page 1 of 8Next →

Frequent Co-authors

Naoshi Nishida(31), Masatoshi Kudo(29), Satoru Hagiwara(28), Kazuomi Ueshima(27), Yasunori Minami(25), Masahiro Takita(23), Toshiharu Sakurai(17), Hirokazu Chishina(16), Tomohiro Minami(14), Tomohiro Watanabe(12), Tomoko Aoki(11), Masahiro Morita(11), Yoshiaki Ito(11), Tadaaki Arizumi(10), Yoriaki Komeda(9), Mamoru Takenaka(8), Norihisa Yada(8), Kosei Ito(7), Tsutomu Chiba(7), Shujiro Yazumi(7)